Is bupropion (Wellbutrin) recommended for a 15-year-old with autism spectrum disorder?

Bupropion (Wellbutrin) is NOT recommended as a first-line treatment for a 15-year-old with autism spectrum disorder

Bupropion is not FDA-approved for use in children and adolescents with autism, and there is no evidence supporting its efficacy for core autism symptoms or common co-occurring conditions in this population. 1

Critical FDA Safety Considerations

The FDA label for Wellbutrin carries a black box warning specifically highlighting increased risk of suicidal thoughts and behaviors in children, adolescents, and young adults 1. This is particularly concerning given that:

• Depression and anxiety are common co-occurring conditions in autism
• Autistic adolescents may have difficulty communicating suicidal ideation
• The medication requires close monitoring for worsening symptoms and emergence of suicidal thoughts 1

Evidence-Based Treatment Approach for Autism

For Core Autism Features

No pharmacological treatment, including bupropion, is effective for core social-communication deficits of autism 2. Behavioral interventions remain the primary evidence-based treatment for core autism symptoms 3, 4.

For Co-occurring ADHD (if present)

If your 15-year-old has comorbid ADHD symptoms, the treatment hierarchy differs from non-autistic adolescents:

• First-line: α2-adrenergic agonists (guanfacine, clonidine) are preferred over stimulants in many ASD-ADHD cases 5
• Second-line: Methylphenidate if α2-agonists are insufficient 6, 7
• Not recommended: Bupropion is not among FDA-approved ADHD medications for adolescents 6 and showed limited evidence even in non-autistic adolescents with ADHD 8

For Co-occurring Depression (if present)

If depression is the target, bupropion is not first-line in autism:

• Preferred options: Duloxetine, mirtazapine, or vortioxetine are recommended ahead of both SSRIs and bupropion for depression in ASD 5
• The single study of bupropion in adolescents with ADHD and depression 9 was small (n=24), uncontrolled, and did not include autistic patients

For Irritability/Aggression (if present)

If severe behavioral symptoms are the concern:

• Evidence-based options: Risperidone or aripiprazole are the only FDA-approved medications for irritability in autism (ages 6-17) 4, 7
• Alternative: Guanfacine for less severe cases 5

Why Bupropion Specifically Should Be Avoided

1. No autism-specific evidence: Zero clinical trials demonstrate efficacy in autistic youth 5, 2, 7
2. Seizure risk: Bupropion is contraindicated in patients with seizure disorders 10, and autism is associated with higher seizure prevalence
3. Activation concerns: Can worsen anxiety, agitation, and behavioral dyscontrol—common challenges in autism 1
4. Better alternatives exist: For every potential indication (ADHD, depression, anxiety), there are medications with superior evidence in the ASD population 5

Clinical Algorithm

Step 1: Identify the specific target symptom requiring treatment (not "autism" itself)

• ADHD symptoms → Start with guanfacine or clonidine
• Depression → Consider duloxetine or mirtazapine
• Anxiety → Buspirone or mirtazapine preferred over SSRIs 5
• Severe irritability/aggression → Risperidone or aripiprazole

Step 2: Ensure behavioral interventions are optimized first, as these remain the foundation of autism treatment 3, 4

Step 3: If medication is necessary, choose agents with established safety/efficacy data in autistic adolescents

Step 4: Monitor closely for adverse effects, recognizing that autistic individuals may have difficulty reporting side effects

Common Pitfall to Avoid

Do not extrapolate evidence from non-autistic populations to autistic patients. Medication effectiveness and tolerability differ significantly in ASD 5, 2. The fact that bupropion works for depression or ADHD in neurotypical adolescents does not mean it will work—or be safe—in autistic youth.